Evidence map›Paper›PMID 25395847›Full record

ArticleInternational journal of nanomedicine2014

A histological evaluation and in vivo assessment of intratumoral near infrared photothermal nanotherapy-induced tumor regression.

Hadiyah N Green, Stephanie D Crockett, Dmitry V Martyshkin, Karan P Singh, William E Grizzle, Eben L Rosenthal, Sergey B Mirov

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hadiyah N GreenDepartment of Physics, Center for Optical Sensors and Spectroscopies, The University of Alabama at Birmingham, Birmingham, AL, USA ; Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, AL, USA.
Stephanie D CrockettDepartment of Pediatrics, Division of Neonatology, The University of Alabama at Birmingham, Birmingham, AL, USA.
Dmitry V MartyshkinDepartment of Physics, Center for Optical Sensors and Spectroscopies, The University of Alabama at Birmingham, Birmingham, AL, USA.
Karan P SinghComprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, AL, USA ; Department of Medicine, Division of Preventive Medicine, Biostatistics and Bioinformatics Shared Facility, The University of Alabama at Birmingham, Birmingham, AL, USA.
William E GrizzleComprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, AL, USA ; Department of Pathology, Division of Otolaryngology, Head and Neck Surgery, The University of Alabama at Birmingham, Birmingham, AL, USA.
Eben L RosenthalComprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, AL, USA ; Department of Surgery, Division of Otolaryngology, Head and Neck Surgery, The University of Alabama at Birmingham, Birmingham, AL, USA.
Sergey B MirovDepartment of Physics, Center for Optical Sensors and Spectroscopies, The University of Alabama at Birmingham, Birmingham, AL, USA.

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
TRAINING AND CAREER DEVELOPMENTU54CA118948 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI UPENDER MANNE · 2005 to 2026
$26.6M
Research Education CoreU54CA118623 · NCI · TUSKEGEE UNIVERSITY · PI Vivian L Carter, TIMOTHY TURNER · 2005 to 2026
$20.2M
INFRASTRUCTURE IIG12MD007585 · NIMHD · TUSKEGEE UNIVERSITY · PI YATES, CLAYTON · 2012 to 2016
$4.6M
Fluorescently Labeled Anti-EGFR to Guide Removal of Lymph Node MetastasisR21DE019232 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ROSENTHAL, EBEN L. · 2009 to 2010
$403k
NCI NIH HHS 2U54CA118948NCI NIH HHS P30 CA013148NCI NIH HHS P30 CA13148NCI NIH HHS U54 CA118623NCI NIH HHS U54 CA118948NIDCR NIH HHS 1R21DE019232-01A2NIDCR NIH HHS R21 DE019232NIMHD NIH HHS G12 MD007585
6 · The paper itself

Abstract

purposeNanoparticle (NP)-enabled near infrared (NIR) photothermal therapy has realized limited success in in vivo studies as a potential localized cancer therapy. This is primarily due to a lack of successful methods that can prevent NP uptake by the reticuloendothelial system, especially the liver and kidney, and deliver sufficient quantities of intravenously injected NPs to the tumor site. Histological evaluation of photothermal therapy-induced tumor regression is also neglected in the current literature. This report demonstrates and histologically evaluates the in vivo potential of NIR photothermal therapy by circumventing the challenges of intravenous NP delivery and tumor targeting found in other photothermal therapy studies.

methodsSubcutaneous Cal 27 squamous cell carcinoma xenografts received photothermal nanotherapy treatments, radial injections of polyethylene glycol (PEG)-ylated gold nanorods and one NIR 785 nm laser irradiation for 10 minutes at 9.5 W/cm(2). Tumor response was measured for 10-15 days, gross changes in tumor size were evaluated, and the remaining tumors or scar tissues were excised and histologically analyzed.

resultsThe single treatment of intratumoral nanorod injections followed by a 10 minute NIR laser treatment also known as photothermal nanotherapy, resulted in ~100% tumor regression in ~90% of treated tumors, which was statistically significant in a comparison to the average of all three control groups over time (P<0.01).

conclusionPhotothermal nanotherapy, or intratumoral nanorod injections followed by NIR laser irradiation of tumors and tumor margins, demonstrate the potential of NIR photothermal therapy as a viable localized treatment approach for primary and early stage tumors, and prevents NP uptake by the reticuloendothelial system.

Indexed as

AnimalsAntineoplastic AgentsCarcinoma, Squamous CellCell Line, TumorCell SurvivalFemaleGoldHumansHyperthermia, InducedLasersMiceMice, NudeNanotubesPhototherapyPolyethylene GlycolsXenograft Model Antitumor AssaysAntineoplastic AgentsGoldPolyethylene Glycolscancer treatmentgold nanorodsintratumorallaser therapymalignancynanoparticlesPEGylationphotothermal cancer therapy

Identifiers

PMID25395847
PMCPMC4227627

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.